No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents, Immunological / adverse effects*
-
Antineoplastic Agents, Immunological / therapeutic use
-
Autoimmune Diseases / blood
-
Autoimmune Diseases / chemically induced*
-
Autoimmune Diseases / diagnostic imaging
-
Biomarkers
-
Diffusion Magnetic Resonance Imaging
-
Exocrine Pancreatic Insufficiency / etiology
-
Fluorine Radioisotopes
-
Fluorodeoxyglucose F18
-
Humans
-
Immunotherapy / adverse effects*
-
Lipase / blood
-
Male
-
Melanoma / drug therapy
-
Melanoma / secondary
-
Middle Aged
-
Molecular Targeted Therapy / adverse effects*
-
Neoplasm Proteins / antagonists & inhibitors*
-
Nivolumab / adverse effects*
-
Nivolumab / therapeutic use
-
Pancreatitis / blood
-
Pancreatitis / chemically induced*
-
Pancreatitis / diagnostic imaging
-
Pancreatitis / immunology
-
Positron Emission Tomography Computed Tomography
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
-
Radiopharmaceuticals
Substances
-
Antineoplastic Agents, Immunological
-
Biomarkers
-
Fluorine Radioisotopes
-
Neoplasm Proteins
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor
-
Radiopharmaceuticals
-
Fluorodeoxyglucose F18
-
Nivolumab
-
Lipase
-
Fluorine-18